Ways and Waves of MALT1 Paracaspase Activation

Total Page:16

File Type:pdf, Size:1020Kb

Ways and Waves of MALT1 Paracaspase Activation Cellular & Molecular Immunology (2018) 15, 8–11 & 2018 CSI and USTC All rights reserved 2042-0226/18 $32.00 www.nature.com/cmi RESEARCH HIGHLIGHT Ways and waves of MALT1 paracaspase activation Laura Israël and Frédéric Bornancin Cellular & Molecular Immunology (2018) 15, 8–11; doi:10.1038/cmi.2017.77; published online 7 August 2017 ucosa-associated lymphoid tissue invariant natural killer T (iNKT) cells catalytic function of MALT1 was finally Mlymphoma translocation protein 1 activates caspase-1 by recruiting MALT1 elucidated.6 MALT1 was identified as a (MALT1), also known as paracaspase 1, in a TRAF6-dependent manner that Cys-dependent, Arg-specificprotease, is a ubiquitous protease with homology might bypass CBM formation.2 In the leading to the discovery of several to caspases.1 The function of MALT1 is second study, Thome and colleagues MALT1 proteolytic substrates.5 Further- best understood in immune cells, in show that two Kaposi’ssarcoma-more, constitutive MALT1 protease activ- particular lymphocytes, in which associated herpes virus (KSHV) proteins ity was discovered in diffuse large B-cell MALT1 controls signaling downstream promote NF-κB activation via binding to lymphomas (DLBCL) of the activated of antigen receptors, for example, MALT1 and activating its paracaspase B-cell (ABC) subtype, which are charac- nuclear-factor-kappa-B (NF-κB) and activity, likely in a CBM-independent terized by chronic stimulation of the mitogen-activated protein kinase manner.3 These findings are highlighted B-cell receptor pathway, as a result of pathways. Activation of MALT1 below and show how emerging concepts somatic mutations in some of the paracaspase activity has been shown to continue to push the current boundaries signaling components. In particular, require the assembly of a tripartite of our understanding of the function CARD11 gain-of-function mutations signaling complex termed CBM of MALT1. were characterized,7 which contributed (CARD11/BCL10/MALT1), which is MALT1 was discovered some 20 years to the establishment that CBM assembly formed following the phosphorylation ago as a proto-oncogenic translocation is a keystone for MALT1 protease activa- and conformational change of caspase product that accounted for antibiotic tion (Figure 1). recruitmentdomain11(CARD11)that resistance in MALT lymphoma patients.4 The recent work by Li and colleagues, is induced by antigen-receptor Subsequently, the CARMA protein family published in the June issue of The stimulation. This complex then recruits was identified, and MALT1 was shown to Journal of Clinical Investigation,2 showed theE3ligasetumornecrosisfactor be an essential component of so-called that OX40, a TNF superfamily receptor receptor-associated factor 6 (TRAF6), CBM complexes composed of CARMA1, (TNFRSF4), can activate the MALT1 which leads to the activation of the also known as CARD11, B-cell lym- protease in iNKT cells. Although nor- inhibitor-of-kappa-B kinase (IκK) phoma 10 (BCL10) and MALT1, which mally associated with T-cell survival, complex, an essential step in the release assemble upon antigen-receptor-driven effector differentiation and memory gen- of transcriptionally active NF-κB. Now, stimulation in lymphocytes.5 In addition eration, this study uncovered that OX40 according to recent studies, there might to CARMA1, other CARD containing signaling in iNKT cells instead leads to be alternative mechanisms for MALT1 proteins, for example, CARD9, CARMA2 caspase-1-dependent programmed cell activation that do not rely on the (CARD14) and CARMA3 (CARD10), death, also known as pyroptosis. recruitment into CBM complexes. In have been shown to build similar CBM Furthermore, in TRAF6-deficient the first study, Li and colleagues show complexes in response to various ligands iNKT cells, OX40 failed to induce that the OX40 signaling pathway in in several cell types. They are involved, caspase-1 activation, as shown by the either downstream of receptors/co-recep- absence of caspase-1 cleavage using tors displaying immune-receptor tyro- immunoblotting and flow cytometry Novartis Institutes for BioMedical Research, sine-based activation motifs in their methods. Next, using an immunopreci- Novartis Campus, Basel CH-4002, Switzerland cytoplasmic domain, through a cascade pitation approach with FACS-sorted Correspondence: Dr Frédéric Bornancin, Novartis of phosphorylation-induced recruitment iNKT cells stimulated with OX40 Institutes for BioMedical Research, Novartis Cam- fi pus, Basel CH-4002, Switzerland. of signaling molecules, or downstream of ligand in vitro, the authors identi ed E-mail: [email protected] G-protein-coupled receptors by unknown BCL10 and MALT1 as TRAF6 interac- Received: 30 June 2017; Accepted: 1 July 2017 mechanisms. In 2008, the long elusive tors. By overexpressing TRAF6, MALT1 paracaspase activation LIsraëlandFBornancin 9 receptor pathway represents an interest- ing case to investigate because it is known to recruit several TRAF isoforms via its scaffold protein, ACT1 (NF-κB- activating protein 1), including TRAF2 and TRAF6(ref. 13) (Figure 2). Another recent study by Thome and colleagues,3 published in the March issue of Leukemia,unveiledakeyrolefor MALT1 in primary effusion lymphoma (PEL), which is a subtype of non-Hodg- kin’s B-cell lymphoma caused by KSHV. Inhibiting the constitutive protease func- tion of MALT1 in PEL induced a switch from the latent to the lytic stage of viral infection, leading to PEL cell death Figure 1 The waves of MALT1 activation. MALT1 is recruited into CARD/BCL10/MALT1 in vitro and to reduced tumor size (CBM) complexes after stimulation of antigen receptors or under chronic stimulatory conditions resulting from mutations in signaling components of the pathway, for example, in vivo using a xenograft model. Remark- gain-of-function (GoF) mutations in CARD11. CBM assembly triggers MALT1 paracaspase ably, PEL cell lines do not express Bruton activity. MALT1 cleaves several substrates including BCL10. MALT1 can also auto-cleave, tyrosine kinase (BTK) and, consistently, particularly at R149,8 which is promoted by TRAF6.9 This process represents a feed-forward were not sensitive to the BTK inhibitor mechanism that releases a highly functional MALT1 species. MALT1 auto proteolysis, and ibrutinib, in contrast to HBL-1 cells, 9 cleavage of BCL10 by MALT1 may contribute to downregulation of the pathway. which are an example of an ABC- DLBCL lymphoma cell line that responds MALT1 and caspase-1 in 293T cells, therefore, classical CBM complex assem- to both BTK and MALT1 inhibition. they observed that TRAF6 fails to co- bly appears unlikely. OX40-induced Furthermore, these cell lines do not immunoprecipitate with caspase-1 in recruitment of protein kinase C together express detectable amounts of CARMA1, the absence of MALT1, suggesting with CBM molecules into a TRAF2 CARMA3 or CARD9. Together, this find- that MALT1 is a critical component for complex was proposed previously;11 ing led the authors propose that MALT1 TRAF6-mediated activation of caspase-1. however, the mechanism has remained activation in PEL likely occurs indepen- Binding of BCL10 to MALT1 also incompletely characterized. In the mean- dently of the BTK-CARMA axis. To appears to be key because deletion of time, new insights have been obtained. identify mechanisms that activate MALT1 the N-terminal region of MALT1—a First, shorter isoforms of CARD proteins in latently infected PEL cells, they region previously shown to contain key were reported to be able to interact with screened an expression library of 86 open determinants of BCL10 binding—abro- TRAF2.12 Second, the E3 ligase activity of reading frames (ORFs) encoded by the gated recruitment of caspase-1 into the TRAF6 was shown to be activated down- KSHV genome and found ORFs K13 and MALT1-TRAF6 complex. Additionally, stream of OX40.10 Third, a recent report K15, which are two known NF-κB-indu- a MALT1 protease inhibitor could indicated that TRAF6 induces self- cing proteins expressed during viral block the cleavage of caspase-1 in a cleavage of MALT1, which has an impact latency, to be the most potent hits. Both concentration-dependent manner, thus on the activation cycle of MALT1 K13 and K15 promoted MALT1 activa- suggesting the involvement of MALT1 (Figure 1). That study also raised tion in a concentration-dependent man- paracaspase activity in caspase-1 activa- the possibility that TRAF6 might be ner and induced MALT1 mono- tion. Collectively, these data suggested able to activate the MALT1 protease ubiquitination, which was previously that in iNKT cells, activation of the directly, independently of CBM complex shown to positively correlate with para- OX40 pathway recruits MALT1-BCL10 formation.9 Together, these recent caspase activity.14 Using a pull-down through TRAF6, and MALT1 then acti- insights suggest that MALT1, either approach, they provided evidence that vates caspase-1 to induce cellular pyrop- directly or after release from assembly the cytoplasmic K13 protein activates tosis. Whether cleavage of caspase-1 is into a CBM complex, or even as part of a MALT1 and consequently NF-κBvia directly performed by MALT1 or if there CBM complex—perhaps involving a binding to its protease domain, either is an intermediate regulator, however, short CARD isoform12 —might be able directly or via an additional binding remains to be clarified. to reach signaling hubs coated with partner. The transmembrane K15 protein, This study is the first report of a TNF TRAF proteins, such as those down- which does not bind MALT1, most likely superfamily receptor that can trigger stream of TNF ligand family receptors, activates it via recruitment of additional MALT1 paracaspase activity. Notably, such as OX40.10 Expanding along these signaling proteins through its cytoplasmic the cytoplasmic domain of OX40 bears lines, other pathways might be able to SH2-binding motif. How K13 and K15, TRAF2 recruitment motifs,10 and, recruit MALT1. For instance, the IL-17 respectively, activate MALT1 remains to Cellular & Molecular Immunology MALT1 paracaspase activation LIsraëlandFBornancin 10 Figure 2 Toward novel ways of MALT1 activation?. ‘The path of reference’ represents the classical pathway of MALT1 activation as depicted in Figure 1.
Recommended publications
  • The CARMA3-Bcl10-MALT1 Signalosome Drives NF-Κb Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer
    Author Manuscript Published OnlineFirst on December 19, 2017; DOI: 10.1158/0008-5472.CAN-17-1089 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Molecular and Cellular Pathobiology .. The CARMA3-Bcl10-MALT1 Signalosome Drives NF-κB Activation and Promotes Aggressiveness in Angiotensin II Receptor-positive Breast Cancer. Prasanna Ekambaram1, Jia-Ying (Lloyd) Lee1, Nathaniel E. Hubel1, Dong Hu1, Saigopalakrishna Yerneni2, Phil G. Campbell2,3, Netanya Pollock1, Linda R. Klei1, Vincent J. Concel1, Phillip C. Delekta4, Arul M. Chinnaiyan4, Scott A. Tomlins4, Daniel R. Rhodes4, Nolan Priedigkeit5,6, Adrian V. Lee5,6, Steffi Oesterreich5,6, Linda M. McAllister-Lucas1,*, and Peter C. Lucas1,* 1Departments of Pathology and Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 2Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania 3McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 4Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 5Women’s Cancer Research Center, Magee-Womens Research Institute, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 6Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania Current address for P.C. Delekta: Department of Microbiology & Molecular Genetics, Michigan State University, East Lansing, Michigan Current address for D.R. Rhodes: Strata
    [Show full text]
  • The LUBAC Participates in Lysophosphatidic Acid-Induced NF-Κb Activation
    bioRxiv preprint doi: https://doi.org/10.1101/2020.02.13.948125; this version posted February 13, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The LUBAC participates in Lysophosphatidic Acid-induced NF-κB Activation Tiphaine Douanne1, Sarah Chapelier1, Robert Rottapel2, Julie Gavard1,3, Nicolas Bidère1,* 1Université de Nantes, INSERM, CNRS, CRCINA, Team SOAP, F-440000 Nantes, France; 2Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada ; 3Institut de Cancérologie de l’Ouest, Site René Gauducheau, 44800 Saint-Herblain, France *Author for correspondence: [email protected] Abstract The natural bioactive glycerophospholipid lysophosphatidic acid (LPA) binds to its cognate G protein-coupled receptors (GPCRs) on the cell surface to promote the activation of several transcription factors, including NF-κB. LPA-mediated activation of NF-κB relies on the formation of a signalosome that contains the scaffold CARMA3, the adaptor BCL10 and the paracaspase MALT1 (CBM complex). The CBM has been extensively studied in lymphocytes, where it links antigen receptors to NF-κB activation via the recruitment of the linear ubiquitin assembly complex (LUBAC), a tripartite complex of HOIP, HOIL1 and SHARPIN. Moreover, MALT1 cleaves the LUBAC subunit HOIL1 to further enhance NF- κB activation. However, the contribution of the LUBAC downstream of GPCRs has not been investigated. By using murine embryonic fibroblasts from mice deficient for HOIP, HOIL1 and SHARPIN, we report that the LUBAC is crucial for the activation of NF-κB in response to LPA. Further echoing the situation in lymphocytes, LPA unbridles the protease activity of MALT1, which cleaves HOIL1 at the Arginine 165.
    [Show full text]
  • Structural and Functional Diversity of Caspase Homologues in Non-Metazoan Organisms
    Protoplasma DOI 10.1007/s00709-017-1145-5 REVIEW ARTICLE Structural and functional diversity of caspase homologues in non-metazoan organisms Marina Klemenčič1,2 & Christiane Funk1 Received: 1 June 2017 /Accepted: 5 July 2017 # The Author(s) 2017. This article is an open access publication Abstract Caspases, the proteases involved in initiation and supports the role of metacaspases and orthocaspases as im- execution of metazoan programmed cell death, are only pres- portant contributors to cell homeostasis during normal physi- ent in animals, while their structural homologues can be ological conditions or cell differentiation and ageing. found in all domains of life, spanning from simple prokary- otes (orthocaspases) to yeast and plants (metacaspases). All members of this wide protease family contain the p20 do- Keywords Algae . Cyanobacteria . Cell death . Cysteine main, which harbours the catalytic dyad formed by the two protease . Metacaspase . Orthocaspase amino acid residues, histidine and cysteine. Despite the high structural similarity of the p20 domain, metacaspases and orthocaspases were found to exhibit different substrate speci- ficities than caspases. While the former cleave their substrates Introduction after basic amino acid residues, the latter accommodate sub- strates with negative charge. This observation is crucial for BOut of life’s school of war: What does not destroy me, the re-evaluation of non-metazoan caspase homologues being makes me stronger.^ wrote the German philosopher involved in processes of programmed cell death. In this re- Friedrich Nietzsche in his book Twilight of the Idols or view, we analyse the structural diversity of enzymes contain- how to philosophize with a hammer. Even though ing the p20 domain, with focus on the orthocaspases, and reformatted to more common use, this phrase has been summarise recent advances in research of orthocaspases and used to describe the dual nature of caspase homologues metacaspases of cyanobacteria, algae and higher plants.
    [Show full text]
  • PRKCQ / PKC-Theta Antibody (Aa640-690) Rabbit Polyclonal Antibody Catalog # ALS16240
    10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 PRKCQ / PKC-Theta Antibody (aa640-690) Rabbit Polyclonal Antibody Catalog # ALS16240 Specification PRKCQ / PKC-Theta Antibody (aa640-690) - Product Information Application WB, IHC Primary Accession Q04759 Reactivity Human, Mouse, Rat Host Rabbit Clonality Polyclonal Calculated MW 82kDa KDa PRKCQ / PKC-Theta Antibody (aa640-690) - Additional Information Gene ID 5588 Other Names Protein kinase C theta type, 2.7.11.13, Western blot of PKC (N670) pAb in extracts nPKC-theta, PRKCQ, PRKCT from A549 cells. Target/Specificity Human PKC Theta Reconstitution & Storage Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Precautions PRKCQ / PKC-Theta Antibody (aa640-690) is for research use only and not for use in diagnostic or therapeutic procedures. Anti-PRKCQ / PKC-Theta antibody IHC staining of human brain, cerebellum. PRKCQ / PKC-Theta Antibody (aa640-690) - Protein Information PRKCQ / PKC-Theta Antibody (aa640-690) - Name PRKCQ Background Synonyms PRKCT Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent Function serine/threonine-protein kinase that mediates Calcium-independent, phospholipid- and non- redundant functions in T-cell receptor diacylglycerol (DAG)- dependent (TCR) signaling, including T-cells activation, serine/threonine-protein kinase that proliferation, differentiation and survival, by mediates non-redundant functions in T-cell mediating activation of multiple transcription receptor (TCR) signaling, including T-cells factors such as NF-kappa-B, JUN, NFATC1 and activation, proliferation, differentiation and NFATC2. In TCR-CD3/CD28-co-stimulated Page 1/3 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 survival, by mediating activation of multiple T-cells, is required for the activation of transcription factors such as NF-kappa-B, NF-kappa-B and JUN, which in turn are JUN, NFATC1 and NFATC2.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • RSC Chemical Biology
    RSC Chemical Biology View Article Online PAPER View Journal | View Issue Phosphinate esters as novel warheads for activity-based probes targeting serine proteases† Cite this: RSC Chem. Biol., 2021, 2, 1285 Jan Pascal Kahler a and Steven H. L. Verhelst *ab Activity-based protein profiling enables the specific detection of the active fraction of an enzyme and is of particular use for the profiling of proteases. The technique relies on a mechanism-based reaction between Received 21st May 2021, small molecule activity-based probes (ABPs) with the active enzyme. Here we report a set of new ABPs for Accepted 7th July 2021 serine proteases, specifically neutrophil serine proteases. The probes contain a phenylphosphinate warhead DOI: 10.1039/d1cb00117e that mimics the P1 amino acid recognized by the primary recognition pocket of S1 family serine proteases. The warhead is easily synthesized from commercial starting materials and leads to potent probes which can rsc.li/rsc-chembio be used for fluorescent in-gel protease detection and fluorescent microscopy imaging experiments. Creative Commons Attribution-NonCommercial 3.0 Unported Licence. Introduction Serine proteases are the largest group of proteases. They use an active site serine residue for attack on the scissile peptide bond. Activity-based protein profiling (ABPP) is a powerful technique Many serine reactive electrophiles such as isocoumarins,13,14 that allows for profiling of the active fraction of a given enzyme. It benzoxazinones,15 phosphoramidates16 and oxolactams17 have has been particularly useful for the study of proteases, because been used as warhead for serine protease ABPs. Most applied these enzymes are tightly regulated by post-translational however, are a-aminoalkyl diphenyl phosphonates.18,19 Since these processes.1–3 ABPP relies on activity-based probes (ABPs), small phosphonates bind to the serine protease in a substrate-like molecules that react covalently with the active enzyme in a manner, substrate specificity information can directly be used to mechanism-based manner.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • NF-B in Hematological Malignancies
    biomedicines Review NF-κB in Hematological Malignancies Véronique Imbert * and Jean-François Peyron Centre Méditerranéen de Médecine Moléculaire, INSERM U1065, Université Côte d’Azur, 06204 Nice, France; [email protected] * Correspondence: [email protected]; Tel.: +33-489-064-315 Academic Editor: Véronique Baud Received: 28 April 2017; Accepted: 26 May 2017; Published: 31 May 2017 Abstract: NF-κB (Nuclear Factor K-light-chain-enhancer of activated B cells) transcription factors are critical regulators of immunity, stress response, apoptosis, and differentiation. Molecular defects promoting the constitutive activation of canonical and non-canonical NF-κB signaling pathways contribute to many diseases, including cancer, diabetes, chronic inflammation, and autoimmunity. In the present review, we focus our attention on the mechanisms of NF-κB deregulation in hematological malignancies. Key positive regulators of NF-κB signaling can act as oncogenes that are often prone to chromosomal translocation, amplifications, or activating mutations. Negative regulators of NF-κB have tumor suppressor functions, and are frequently inactivated either by genomic deletions or point mutations. NF-κB activation in tumoral cells is also driven by the microenvironment or chronic signaling that does not rely on genetic alterations. Keywords: NF-κB; leukemia; lymphoma 1. Introduction The NF-κB family of transcription factors coordinates inflammatory responses, innate and adaptive immunity, cellular differentiation, proliferation, and survival in all multicellular organisms. The NF-κB system is tightly controlled at various levels, and deregulations of NF-κB homeostasis have been implicated in a wide range of diseases, ranging from inflammatory and immune disorders to cancer [1,2]. In particular, NF-κB is a key link between chronic inflammation and cancer transformation [3].
    [Show full text]
  • NIH Public Access Author Manuscript Mol Psychiatry
    NIH Public Access Author Manuscript Mol Psychiatry. Author manuscript; available in PMC 2014 July 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Mol Psychiatry. 2013 July ; 18(7): 781–787. doi:10.1038/mp.2013.24. Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment K Nho1, JJ Corneveaux2, S Kim1,3, H Lin3, SL Risacher1, L Shen1,3, S Swaminathan1,4, VK Ramanan1,4, Y Liu3,4, T Foroud1,3,4, MH Inlow5, AL Siniard2, RA Reiman2, PS Aisen6, RC Petersen7, RC Green8, CR Jack7, MW Weiner9,10, CT Baldwin11, K Lunetta12, LA Farrer11,13, SJ Furney14,15,16, S Lovestone14,15,16, A Simmons14,15,16, P Mecocci17, B Vellas18, M Tsolaki19, I Kloszewska20, H Soininen21, BC McDonald1,22, MR Farlow22, B Ghetti23, MJ Huentelman2, and AJ Saykin1,3,4,22 for the Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study; for the AddNeuroMed Consortium; for the Indiana Memory and Aging Study; for the Alzheimer’s Disease Neuroimaging Initiative (ADNI)24 1Department of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USA 2Neurogenomics Division, The Translational Genomics Research Institute (TGen), Phoenix, AZ, USA 3Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN, USA 4Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN,
    [Show full text]
  • Phylogenetic Distribution and Diversity of Bacterial Pseudo-Orthocaspases Underline Their Putative Role in Photosynthesis
    http://www.diva-portal.org This is the published version of a paper published in Frontiers in Plant Science. Citation for the original published paper (version of record): Klemenčič, M., Asplund-Samuelsson, J., Dolinar, M., Funk, C. (2019) Phylogenetic Distribution and Diversity of Bacterial Pseudo-Orthocaspases Underline Their Putative Role in Photosynthesis Frontiers in Plant Science, 10: 293 https://doi.org/10.3389/fpls.2019.00293 Access to the published version may require subscription. N.B. When citing this work, cite the original published paper. Permanent link to this version: http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157749 fpls-10-00293 March 12, 2019 Time: 19:11 # 1 ORIGINAL RESEARCH published: 14 March 2019 doi: 10.3389/fpls.2019.00293 Phylogenetic Distribution and Diversity of Bacterial Pseudo-Orthocaspases Underline Their Putative Role in Photosynthesis Marina Klemenciˇ cˇ 1,2, Johannes Asplund-Samuelsson3, Marko Dolinar2 and Christiane Funk1* 1 Department of Chemistry, Umeå University, Umeå, Sweden, 2 Department of Chemistry and Biochemistry, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia, 3 Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Solna, Sweden Orthocaspases are prokaryotic caspase homologs – proteases, which cleave their substrates after positively charged residues using a conserved histidine – cysteine (HC) dyad situated in a catalytic p20 domain. However, in orthocaspases pseudo-variants have been identified, which instead of the catalytic HC residues contain tyrosine and Edited by: serine, respectively. The presence and distribution of these presumably proteolytically Mercedes Diaz-Mendoza, inactive p20-containing enzymes has until now escaped attention.
    [Show full text]
  • The Roles of Malt1 in Nf-Κb Activation and Solid Tumor Progression
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 5-2016 THE ROLES OF MALT1 IN NF-κB ACTIVATION AND SOLID TUMOR PROGRESSION Deng Pan Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Animal Diseases Commons, Animals Commons, Biochemistry Commons, Cancer Biology Commons, Cell Biology Commons, Disease Modeling Commons, Molecular Biology Commons, Molecular Genetics Commons, and the Oncology Commons Recommended Citation Pan, Deng, "THE ROLES OF MALT1 IN NF-κB ACTIVATION AND SOLID TUMOR PROGRESSION" (2016). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 651. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/651 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. THE ROLES OF MALT1 IN NF-κB ACTIVATION AND SOLID TUMOR PROGRESSION by Deng Pan, B.S. APPROVED: ______________________________ Xin Lin, Ph.D. , Advisory Professor ______________________________ Paul Chiao, Ph.D. ______________________________ Dos Sarbassov, Ph.D. ______________________________ M. James You, M.D., Ph.D. ______________________________ Chengming Zhu, Ph.D.
    [Show full text]
  • Anticancer Activity of Lesbicoumestan in Jurkat Cells Via Inhibition of Oxidative Stress-Mediated Apoptosis and MALT1 Protease
    molecules Article Anticancer Activity of Lesbicoumestan in Jurkat Cells via Inhibition of Oxidative Stress-Mediated Apoptosis and MALT1 Protease Joo-Eun Lee 1,† , Fang Bo 2,†, Nguyen Thi Thanh Thuy 2,† , Jaewoo Hong 3 , Ji Shin Lee 4 , Namki Cho 2,* and Hee Min Yoo 5,* 1 Stem Cell Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea; [email protected] 2 College of Pharmacy, Chonnam National University, Gwangju 61186, Korea; [email protected] (F.B.); [email protected] (N.T.T.T.) 3 Department of Physiology, Daegu Catholic University School of Medicine, Daegu 42472, Korea; [email protected] 4 Department of Pathology, Chonnam National University Medical School, Gwangju 61469, Korea; [email protected] 5 Biometrology Group, Korea Research Institute of Standards and Science (KRISS), Daejeon 34113, Korea * Correspondence: [email protected] (N.C.); [email protected] (H.M.Y.); Tel.: +82-62-530-2925 (N.C.); +82-42-868-5362 (H.M.Y.) † These authors contributed equally to this paper. Abstract: This study explores the potential anticancer effects of lesbicoumestan from Lespedeza bicolor against human leukemia cancer cells. Flow cytometry and fluorescence microscopy were used to investigate antiproliferative effects. The degradation of mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) was evaluated using immunoprecipitation, Western blotting, and confocal microscopy. Apoptosis was investigated using three-dimensional (3D) Jurkat Citation: Lee, J.-E.; Bo, F.; Thuy, cell resistance models. Lesbicoumestan induced potent mitochondrial depolarization on the Jurkat N.T.T.; Hong, J.; Lee, J.S.; Cho, N.; cells via upregulated expression levels of mitochondrial reactive oxygen species.
    [Show full text]